EAST has reached its next Milestone!

EAST – AFNET 4 has reached its next milestone:
the end of follow-up for all patients in the trial. In
the beginning of March 2020 the EAST sponsor,
AFNET, came to this decision following a recommendation
from the Data and Safety Monitoring
Board (DSMB) and the Executive Steering Committee
(eSC). Now the study results are in sight.Patient enrolment started in summer of 2011.
Until the end of 2016, a total of 2789 patients
from 135 study sites in 11 European countries
were included into the trial and followed up for
several years.